ID   AGRE2_HUMAN             Reviewed;         823 AA.
AC   Q9UHX3; B4DQ96; E7ESD7; E9PBR1; E9PEL6; E9PFQ5; E9PG91; Q8NG96;
AC   Q9Y4B1;
DT   01-MAR-2004, integrated into UniProtKB/Swiss-Prot.
DT   13-JUN-2006, sequence version 2.
DT   22-JUL-2015, entry version 146.
DE   RecName: Full=Adhesion G protein-coupled receptor E2 {ECO:0000303|PubMed:25713288};
DE   AltName: Full=EGF-like module receptor 2;
DE   AltName: Full=EGF-like module-containing mucin-like hormone receptor-like 2;
DE   AltName: CD_antigen=CD312;
DE   Flags: Precursor;
GN   Name=ADGRE2 {ECO:0000312|HGNC:HGNC:3337}; Synonyms=EMR2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), TISSUE SPECIFICITY,
RP   ALTERNATIVE SPLICING (ISOFORMS 2; 3; 4 AND 5), AND VARIANT PHE-614.
RX   PubMed=10903844; DOI=10.1006/geno.2000.6238;
RA   Lin H.-H., Stacey M., Hamann J., Gordon S., McKnight A.J.;
RT   "Human EMR2, a novel EGF-TM7 molecule on chromosome 19p13.1, is
RT   closely related to CD97.";
RL   Genomics 67:188-200(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Suwa M., Sato T., Okouchi I., Arita M., Futami K., Matsumoto S.,
RA   Tsutsumi S., Aburatani H., Asai K., Akiyama Y.;
RT   "Genome-wide discovery and analysis of human seven transmembrane helix
RT   receptor genes.";
RL   Submitted (JUL-2001) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 6), AND VARIANT
RP   PHE-614.
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT PHE-614.
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J.,
RA   Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M.,
RA   Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E.,
RA   Caenepeel S., Carrano A.V., Caoile C., Chan Y.M., Christensen M.,
RA   Cleland C.A., Copeland A., Dalin E., Dehal P., Denys M., Detter J.C.,
RA   Escobar J., Flowers D., Fotopulos D., Garcia C., Georgescu A.M.,
RA   Glavina T., Gomez M., Gonzales E., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Ho I., Huang W., Israni S., Jett J., Kadner K., Kimball H.,
RA   Kobayashi A., Larionov V., Leem S.-H., Lopez F., Lou Y., Lowry S.,
RA   Malfatti S., Martinez D., McCready P.M., Medina C., Morgan J.,
RA   Nelson K., Nolan M., Ovcharenko I., Pitluck S., Pollard M.,
RA   Popkie A.P., Predki P., Quan G., Ramirez L., Rash S., Retterer J.,
RA   Rodriguez A., Rogers S., Salamov A., Salazar A., She X., Smith D.,
RA   Slezak T., Solovyev V., Thayer N., Tice H., Tsai M., Ustaszewska A.,
RA   Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J., Dubchak I.,
RA   Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [5]
RP   PROTEIN SEQUENCE OF 518-527, PROTEOLYTIC PROCESSING, AND MUTAGENESIS
RP   OF SER-518.
RX   PubMed=12860403; DOI=10.1016/S0014-5793(03)00695-1;
RA   Chang G.-W., Stacey M., Kwakkenbos M.J., Hamann J., Gordon S.,
RA   Lin H.-H.;
RT   "Proteolytic cleavage of the EMR2 receptor requires both the
RT   extracellular stalk and the GPS motif.";
RL   FEBS Lett. 547:145-150(2003).
RN   [6]
RP   CHARACTERIZATION, AND TISSUE SPECIFICITY.
RX   PubMed=11994511;
RA   Kwakkenbos M.J., Chang G.-W., Lin H.-H., Pouwels W., de Jong E.C.,
RA   van Lier R.A.W., Gordon S., Hamann J.;
RT   "The human EGF-TM7 family member EMR2 is a heterodimeric receptor
RT   expressed on myeloid cells.";
RL   J. Leukoc. Biol. 71:854-862(2002).
RN   [7]
RP   FUNCTION, AND INTERACTION WITH CHONDROITIN SULFATE.
RX   PubMed=12829604; DOI=10.1182/blood-2002-11-3540;
RA   Stacey M., Chang G.-W., Davies J.Q., Kwakkenbos M.J., Sanderson R.D.,
RA   Hamann J., Gordon S., Lin H.-H.;
RT   "The epidermal growth factor-like domains of the human EMR2 receptor
RT   mediate cell attachment through chondroitin sulfate
RT   glycosaminoglycans.";
RL   Blood 102:2916-2924(2003).
RN   [8]
RP   AUTOPROTEOLYTIC CLEAVAGE, AND SUBUNIT.
RX   PubMed=15150276; DOI=10.1074/jbc.M402974200;
RA   Lin H.H., Chang G.W., Davies J.Q., Stacey M., Harris J., Gordon S.;
RT   "Autocatalytic cleavage of the EMR2 receptor occurs at a conserved G
RT   protein-coupled receptor proteolytic site motif.";
RL   J. Biol. Chem. 279:31823-31832(2004).
RN   [9]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=17928360; DOI=10.1096/fj.07-9435com;
RA   Yona S., Lin H.H., Dri P., Davies J.Q., Hayhoe R.P., Lewis S.M.,
RA   Heinsbroek S.E., Brown K.A., Perretti M., Hamann J., Treacher D.F.,
RA   Gordon S., Stacey M.;
RT   "Ligation of the adhesion-GPCR EMR2 regulates human neutrophil
RT   function.";
RL   FASEB J. 22:741-751(2008).
RN   [10]
RP   FUNCTION.
RX   PubMed=22575658; DOI=10.1016/j.febslet.2012.03.014;
RA   Gupte J., Swaminath G., Danao J., Tian H., Li Y., Wu X.;
RT   "Signaling property study of adhesion G-protein-coupled receptors.";
RL   FEBS Lett. 586:1214-1219(2012).
RN   [11]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=22310662; DOI=10.1128/MCB.06557-11;
RA   Huang Y.S., Chiang N.Y., Hu C.H., Hsiao C.C., Cheng K.F., Tsai W.P.,
RA   Yona S., Stacey M., Gordon S., Chang G.W., Lin H.H.;
RT   "Activation of myeloid cell-specific adhesion class G protein-coupled
RT   receptor EMR2 via ligation-induced translocation and interaction of
RT   receptor subunits in lipid raft microdomains.";
RL   Mol. Cell. Biol. 32:1408-1420(2012).
RN   [12]
RP   NOMENCLATURE.
RX   PubMed=25713288; DOI=10.1124/pr.114.009647;
RA   Hamann J., Aust G., Arac D., Engel F.B., Formstone C., Fredriksson R.,
RA   Hall R.A., Harty B.L., Kirchhoff C., Knapp B., Krishnan A.,
RA   Liebscher I., Lin H.H., Martinelli D.C., Monk K.R., Peeters M.C.,
RA   Piao X., Promel S., Schoneberg T., Schwartz T.W., Singer K.,
RA   Stacey M., Ushkaryov Y.A., Vallon M., Wolfrum U., Wright M.W., Xu L.,
RA   Langenhan T., Schioth H.B.;
RT   "International union of basic and clinical pharmacology. XCIV.
RT   Adhesion G protein-coupled receptors.";
RL   Pharmacol. Rev. 67:338-367(2015).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 25-260, INTERACTION WITH
RP   CD55, CALCIUM-BINDING, AND DISULFIDE BONDS.
RX   PubMed=17449467; DOI=10.1074/jbc.M702588200;
RA   Abbott R.J., Spendlove I., Roversi P., Fitzgibbon H., Knott V.,
RA   Teriete P., McDonnell J.M., Handford P.A., Lea S.M.;
RT   "Structural and functional characterization of a novel T cell receptor
RT   co-regulatory protein complex, CD97-CD55.";
RL   J. Biol. Chem. 282:22023-22032(2007).
CC   -!- FUNCTION: Cell surface receptor that binds to the chondroitin
CC       sulfate moiety of glycosaminoglycan chains and promotes cell
CC       attachment. Promotes granulocyte chemotaxis, degranulation and
CC       adhesion. In macrophages, promotes the release of inflammatory
CC       cytokines, including IL8 and TNF. Signals probably through G-
CC       proteins. {ECO:0000269|PubMed:12829604,
CC       ECO:0000269|PubMed:17928360, ECO:0000269|PubMed:22310662,
CC       ECO:0000269|PubMed:22575658}.
CC   -!- SUBUNIT: Forms a heterodimer, consisting of a large extracellular
CC       region non-covalently linked to a seven-transmembrane moiety.
CC       Interacts with chondroitin sulfate; the interaction with
CC       chondroitin sulfate is calcium-dependent. Interacts with CD55.
CC       {ECO:0000269|PubMed:12829604, ECO:0000269|PubMed:15150276,
CC       ECO:0000269|PubMed:17449467}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:22310662};
CC       Multi-pass membrane protein. Cell projection, ruffle membrane
CC       {ECO:0000269|PubMed:17928360}; Multi-pass membrane protein.
CC       Note=Localized at the leading edge of migrating cells.
CC       {ECO:0000269|PubMed:17928360}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=6;
CC         Comment=A number of isoforms are probably produced. A soluble
CC         form due to a frameshift which introduced a stop codon
CC         immediately before the first TM domain is also detected.;
CC       Name=1;
CC         IsoId=Q9UHX3-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9UHX3-2; Sequence=VSP_041367;
CC       Name=3;
CC         IsoId=Q9UHX3-3; Sequence=VSP_041366;
CC       Name=4;
CC         IsoId=Q9UHX3-4; Sequence=VSP_041365;
CC       Name=5;
CC         IsoId=Q9UHX3-5; Sequence=VSP_041364;
CC       Name=6;
CC         IsoId=Q9UHX3-6; Sequence=VSP_047535;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Expression is restricted to myeloid cells.
CC       Highest expression was found in peripheral blood leukocytes,
CC       followed by spleen and lymph nodes, with intermediate to low
CC       levels in thymus, bone marrow, fetal liver, placenta, and lung,
CC       and no expression in heart, brain, skeletal muscle, kidney, or
CC       pancreas. Expression is also detected in monocyte/macrophage and
CC       Jurkat cell lines but not in other cell lines tested.
CC       {ECO:0000269|PubMed:10903844, ECO:0000269|PubMed:11994511}.
CC   -!- DOMAIN: The GPS domain is necessary, but not sufficient for
CC       receptor cleavage, which require the entire extracellular stalk.
CC       {ECO:0000269|PubMed:12860403}.
CC   -!- DOMAIN: Binding to chondroitin sulfate is mediated by the fourth
CC       EGF domain.
CC   -!- PTM: Autoproteolytically cleaved into 2 subunits, an extracellular
CC       alpha subunit and a seven-transmembrane beta subunit.
CC       {ECO:0000269|PubMed:12860403}.
CC   -!- MISCELLANEOUS: Has no murine ortholog. {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the G-protein coupled receptor 2 family.
CC       Adhesion G-protein coupled receptor (ADGR) subfamily.
CC       {ECO:0000305}.
CC   -!- SIMILARITY: Contains 5 EGF-like domains. {ECO:0000255|PROSITE-
CC       ProRule:PRU00076}.
CC   -!- SIMILARITY: Contains 1 GPS domain. {ECO:0000255|PROSITE-
CC       ProRule:PRU00098}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAC06146.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF114491; AAF21974.1; -; mRNA.
DR   EMBL; AB065931; BAC06146.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AK298700; BAG60858.1; -; mRNA.
DR   EMBL; AC004262; AAC05172.1; -; Genomic_DNA.
DR   EMBL; AC005327; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC090427; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   CCDS; CCDS32935.1; -. [Q9UHX3-1]
DR   CCDS; CCDS59361.1; -. [Q9UHX3-6]
DR   RefSeq; NP_001257981.1; NM_001271052.1. [Q9UHX3-6]
DR   RefSeq; NP_038475.2; NM_013447.3. [Q9UHX3-1]
DR   UniGene; Hs.531619; -.
DR   PDB; 2BO2; X-ray; 2.60 A; A/B=25-260.
DR   PDB; 2BOU; X-ray; 1.90 A; A=25-260.
DR   PDB; 2BOX; X-ray; 2.50 A; A=25-260.
DR   PDBsum; 2BO2; -.
DR   PDBsum; 2BOU; -.
DR   PDBsum; 2BOX; -.
DR   ProteinModelPortal; Q9UHX3; -.
DR   SMR; Q9UHX3; 28-260, 301-517.
DR   STRING; 9606.ENSP00000472280; -.
DR   MEROPS; S63.001; -.
DR   PhosphoSite; Q9UHX3; -.
DR   DMDM; 108935835; -.
DR   MaxQB; Q9UHX3; -.
DR   PaxDb; Q9UHX3; -.
DR   PRIDE; Q9UHX3; -.
DR   Ensembl; ENST00000315576; ENSP00000319883; ENSG00000127507.
DR   Ensembl; ENST00000392965; ENSP00000376692; ENSG00000127507. [Q9UHX3-6]
DR   Ensembl; ENST00000594076; ENSP00000472735; ENSG00000127507. [Q9UHX3-4]
DR   Ensembl; ENST00000594294; ENSP00000470725; ENSG00000127507. [Q9UHX3-3]
DR   Ensembl; ENST00000595839; ENSP00000469277; ENSG00000127507. [Q9UHX3-5]
DR   Ensembl; ENST00000596991; ENSP00000472280; ENSG00000127507. [Q9UHX3-2]
DR   GeneID; 30817; -.
DR   KEGG; hsa:30817; -.
DR   UCSC; uc002mzp.2; human. [Q9UHX3-1]
DR   UCSC; uc031rjs.1; human. [Q9UHX3-2]
DR   CTD; 30817; -.
DR   GeneCards; GC19M014844; -.
DR   H-InvDB; HIX0174383; -.
DR   HGNC; HGNC:3337; ADGRE2.
DR   MIM; 606100; gene.
DR   neXtProt; NX_Q9UHX3; -.
DR   PharmGKB; PA27774; -.
DR   eggNOG; NOG320737; -.
DR   GeneTree; ENSGT00760000118787; -.
DR   HOGENOM; HOG000294115; -.
DR   HOVERGEN; HBG048917; -.
DR   InParanoid; Q9UHX3; -.
DR   KO; K08443; -.
DR   OrthoDB; EOG75J0MK; -.
DR   PhylomeDB; Q9UHX3; -.
DR   TreeFam; TF316380; -.
DR   Reactome; REACT_18372; Class B/2 (Secretin family receptors).
DR   EvolutionaryTrace; Q9UHX3; -.
DR   GeneWiki; EMR2; -.
DR   GenomeRNAi; 30817; -.
DR   NextBio; 35474078; -.
DR   PMAP-CutDB; Q9UHX3; -.
DR   PRO; PR:Q9UHX3; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; Q9UHX3; -.
DR   CleanEx; HS_EMR2; -.
DR   ExpressionAtlas; Q9UHX3; baseline and differential.
DR   Genevisible; Q9UHX3; HS.
DR   GO; GO:0016021; C:integral component of membrane; TAS:GDB.
DR   GO; GO:0031256; C:leading edge membrane; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0032587; C:ruffle membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0035374; F:chondroitin sulfate binding; IMP:UniProtKB.
DR   GO; GO:0004930; F:G-protein coupled receptor activity; TAS:GDB.
DR   GO; GO:0007155; P:cell adhesion; IMP:UniProtKB.
DR   GO; GO:0016477; P:cell migration; IMP:UniProtKB.
DR   GO; GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:GDB.
DR   GO; GO:0071621; P:granulocyte chemotaxis; IMP:UniProtKB.
DR   GO; GO:0006954; P:inflammatory response; IEA:UniProtKB-KW.
DR   InterPro; IPR000742; EG-like_dom.
DR   InterPro; IPR001881; EGF-like_Ca-bd_dom.
DR   InterPro; IPR000152; EGF-type_Asp/Asn_hydroxyl_site.
DR   InterPro; IPR018097; EGF_Ca-bd_CS.
DR   InterPro; IPR017981; GPCR_2-like.
DR   InterPro; IPR003056; GPCR_2_CD97.
DR   InterPro; IPR000832; GPCR_2_secretin-like.
DR   InterPro; IPR017983; GPCR_2_secretin-like_CS.
DR   InterPro; IPR000203; GPS.
DR   InterPro; IPR009030; Growth_fac_rcpt_N_dom.
DR   Pfam; PF00002; 7tm_2; 1.
DR   Pfam; PF07645; EGF_CA; 4.
DR   Pfam; PF01825; GPS; 1.
DR   PRINTS; PR01278; CD97PROTEIN.
DR   PRINTS; PR00249; GPCRSECRETIN.
DR   SMART; SM00179; EGF_CA; 4.
DR   SMART; SM00303; GPS; 1.
DR   SUPFAM; SSF57184; SSF57184; 1.
DR   PROSITE; PS00010; ASX_HYDROXYL; 4.
DR   PROSITE; PS50026; EGF_3; 4.
DR   PROSITE; PS01187; EGF_CA; 4.
DR   PROSITE; PS00650; G_PROTEIN_RECEP_F2_2; 1.
DR   PROSITE; PS50261; G_PROTEIN_RECEP_F2_4; 1.
DR   PROSITE; PS50221; GPS; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Autocatalytic cleavage; Calcium;
KW   Cell adhesion; Cell membrane; Cell projection; Complete proteome;
KW   Direct protein sequencing; Disulfide bond; EGF-like domain;
KW   G-protein coupled receptor; Glycoprotein; Inflammatory response;
KW   Membrane; Polymorphism; Receptor; Reference proteome; Repeat; Signal;
KW   Transducer; Transmembrane; Transmembrane helix.
FT   SIGNAL        1     23       {ECO:0000255}.
FT   CHAIN        24    823       Adhesion G protein-coupled receptor E2.
FT                                /FTId=PRO_0000012875.
FT   TOPO_DOM     24    540       Extracellular. {ECO:0000305}.
FT   TRANSMEM    541    561       Helical; Name=1. {ECO:0000255}.
FT   TOPO_DOM    562    569       Cytoplasmic. {ECO:0000305}.
FT   TRANSMEM    570    590       Helical; Name=2. {ECO:0000255}.
FT   TOPO_DOM    591    605       Extracellular. {ECO:0000305}.
FT   TRANSMEM    606    626       Helical; Name=3. {ECO:0000255}.
FT   TOPO_DOM    627    644       Cytoplasmic. {ECO:0000305}.
FT   TRANSMEM    645    665       Helical; Name=4. {ECO:0000255}.
FT   TOPO_DOM    666    683       Extracellular. {ECO:0000305}.
FT   TRANSMEM    684    704       Helical; Name=5. {ECO:0000255}.
FT   TOPO_DOM    705    735       Cytoplasmic. {ECO:0000305}.
FT   TRANSMEM    736    756       Helical; Name=6. {ECO:0000255}.
FT   TOPO_DOM    757    760       Extracellular. {ECO:0000305}.
FT   TRANSMEM    761    781       Helical; Name=7. {ECO:0000255}.
FT   TOPO_DOM    782    823       Cytoplasmic. {ECO:0000305}.
FT   DOMAIN       25     66       EGF-like 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN       67    118       EGF-like 2; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      119    162       EGF-like 3; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      163    211       EGF-like 4; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      212    260       EGF-like 5; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      479    529       GPS. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00098}.
FT   SITE        517    518       Cleavage; by autolysis.
FT                                {ECO:0000269|PubMed:15150276}.
FT   CARBOHYD     41     41       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    111    111       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    206    206       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    298    298       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    347    347       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    354    354       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    456    456       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    460    460       N-linked (GlcNAc...). {ECO:0000255}.
FT   DISULFID     29     39       {ECO:0000255|PROSITE-ProRule:PRU00076,
FT                                ECO:0000269|PubMed:17449467}.
FT   DISULFID     33     45       {ECO:0000255|PROSITE-ProRule:PRU00076,
FT                                ECO:0000269|PubMed:17449467}.
FT   DISULFID     47     65       {ECO:0000255|PROSITE-ProRule:PRU00076,
FT                                ECO:0000269|PubMed:17449467}.
FT   DISULFID     71     85       {ECO:0000255|PROSITE-ProRule:PRU00076,
FT                                ECO:0000269|PubMed:17449467}.
FT   DISULFID     79     94       {ECO:0000255|PROSITE-ProRule:PRU00076,
FT                                ECO:0000269|PubMed:17449467}.
FT   DISULFID     96    117       {ECO:0000255|PROSITE-ProRule:PRU00076,
FT                                ECO:0000269|PubMed:17449467}.
FT   DISULFID    123    136       {ECO:0000255|PROSITE-ProRule:PRU00076,
FT                                ECO:0000269|PubMed:17449467}.
FT   DISULFID    130    145       {ECO:0000255|PROSITE-ProRule:PRU00076,
FT                                ECO:0000269|PubMed:17449467}.
FT   DISULFID    147    161       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    167    180       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    174    189       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    191    210       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    216    229       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    223    238       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    240    259       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   VAR_SEQ     119    260       Missing (in isoform 5). {ECO:0000305}.
FT                                /FTId=VSP_041364.
FT   VAR_SEQ     119    211       Missing (in isoform 4). {ECO:0000305}.
FT                                /FTId=VSP_041365.
FT   VAR_SEQ     163    211       Missing (in isoform 3). {ECO:0000305}.
FT                                /FTId=VSP_041366.
FT   VAR_SEQ     397    407       Missing (in isoform 2). {ECO:0000305}.
FT                                /FTId=VSP_041367.
FT   VAR_SEQ     473    530       Missing (in isoform 6).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_047535.
FT   VARIANT     314    314       A -> V (in dbSNP:rs35612307).
FT                                /FTId=VAR_061229.
FT   VARIANT     605    605       T -> I (in dbSNP:rs4410209).
FT                                /FTId=VAR_026719.
FT   VARIANT     614    614       L -> F (in dbSNP:rs2524383).
FT                                {ECO:0000269|PubMed:10903844,
FT                                ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15057824}.
FT                                /FTId=VAR_026720.
FT   VARIANT     665    665       S -> F (in dbSNP:rs3752187).
FT                                /FTId=VAR_026721.
FT   VARIANT     720    720       E -> D (in dbSNP:rs57865820).
FT                                /FTId=VAR_061230.
FT   MUTAGEN     518    518       S->A: Abolishes cleavage.
FT                                {ECO:0000269|PubMed:12860403}.
FT   CONFLICT    531    531       Missing (in Ref. 4; AAC05172).
FT                                {ECO:0000305}.
FT   CONFLICT    823    823       N -> R (in Ref. 2; BAC06146).
FT                                {ECO:0000305}.
FT   STRAND       37     43       {ECO:0000244|PDB:2BOU}.
FT   STRAND       45     47       {ECO:0000244|PDB:2BOU}.
FT   STRAND       54     58       {ECO:0000244|PDB:2BOU}.
FT   HELIX        70     72       {ECO:0000244|PDB:2BOU}.
FT   STRAND       74     76       {ECO:0000244|PDB:2BO2}.
FT   STRAND       83     87       {ECO:0000244|PDB:2BOU}.
FT   STRAND       92     96       {ECO:0000244|PDB:2BOU}.
FT   STRAND      100    102       {ECO:0000244|PDB:2BOU}.
FT   STRAND      109    111       {ECO:0000244|PDB:2BOU}.
FT   HELIX       112    114       {ECO:0000244|PDB:2BOU}.
FT   TURN        215    219       {ECO:0000244|PDB:2BOU}.
FT   STRAND      227    231       {ECO:0000244|PDB:2BOU}.
FT   STRAND      236    239       {ECO:0000244|PDB:2BOU}.
FT   STRAND      242    244       {ECO:0000244|PDB:2BOU}.
FT   STRAND      248    250       {ECO:0000244|PDB:2BO2}.
FT   STRAND      252    254       {ECO:0000244|PDB:2BOU}.
SQ   SEQUENCE   823 AA;  90472 MW;  4D38C30A07B46FF4 CRC64;
     MGGRVFLVFL AFCVWLTLPG AETQDSRGCA RWCPQDSSCV NATACRCNPG FSSFSEIITT
     PMETCDDINE CATLSKVSCG KFSDCWNTEG SYDCVCSPGY EPVSGAKTFK NESENTCQDV
     DECQQNPRLC KSYGTCVNTL GSYTCQCLPG FKLKPEDPKL CTDVNECTSG QNPCHSSTHC
     LNNVGSYQCR CRPGWQPIPG SPNGPNNTVC EDVDECSSGQ HQCDSSTVCF NTVGSYSCRC
     RPGWKPRHGI PNNQKDTVCE DMTFSTWTPP PGVHSQTLSR FFDKVQDLGR DYKPGLANNT
     IQSILQALDE LLEAPGDLET LPRLQQHCVA SHLLDGLEDV LRGLSKNLSN GLLNFSYPAG
     TELSLEVQKQ VDRSVTLRQN QAVMQLDWNQ AQKSGDPGPS VVGLVSIPGM GKLLAEAPLV
     LEPEKQMLLH ETHQGLLQDG SPILLSDVIS AFLSNNDTQN LSSPVTFTFS HRSVIPRQKV
     LCVFWEHGQN GCGHWATTGC STIGTRDTST ICRCTHLSSF AVLMAHYDVQ EEDPVLTVIT
     YMGLSVSLLC LLLAALTFLL CKAIQNTSTS LHLQLSLCLF LAHLLFLVAI DQTGHKVLCS
     IIAGTLHYLY LATLTWMLLE ALYLFLTARN LTVVNYSSIN RFMKKLMFPV GYGVPAVTVA
     ISAASRPHLY GTPSRCWLQP EKGFIWGFLG PVCAIFSVNL VLFLVTLWIL KNRLSSLNSE
     VSTLRNTRML AFKATAQLFI LGCTWCLGIL QVGPAARVMA YLFTIINSLQ GVFIFLVYCL
     LSQQVREQYG KWSKGIRKLK TESEMHTLSS SAKADTSKPS TVN
//
